Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02466971
Title Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

cervical adenosquamous carcinoma

cervical adenocarcinoma

cervical squamous cell carcinoma

vaginal cancer

vaginal squamous tumor

Therapies

Cisplatin

Cisplatin + Triapine

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.